# Stroke_HC_v8_2 Analysis Context Document

> ìƒì„±ì¼: 2026-02-12 | ëª©ì : ë¶„ì„ ì»¨í…ìŠ¤íŠ¸ ìš”ì•½ ë° ì‹¤í–‰ ê³„íš

## 1. í”„ë¡œì íŠ¸ ê°œìš”

**Study**: Stroke vs Healthy Control scRNAseq PBMC analysis
- **Stroke**: 12 GEM (10X 5' v2 ST), ~80 patients (IS/ICH/IVH/SAH)
- **HC (Healthy Control)**: 5 GEM (10X 5' v2 HT from 4 HC_GEM), ~20 subjects
- **ì´ ì„¸í¬ìˆ˜**: 226,855 cells / 20,644 genes / 100 subjects

## 2. ë°ì´í„° ì¶œì²˜ ë° íŒŒì´í”„ë¼ì¸

### Pipeline
- **Repository**: `/home/user3/data_user3/git_repo/mypy_re/`
- **Config**: `config/config_local_stroke_hc_v8_2.json`
- **Log**: `logs/pipeline_stroke_hc_v8_2.log` (Pipeline Complete âœ“)

### Pipeline Steps (ì™„ë£Œë¨)
1. `demux_classify` - Souporcell (with known_genotypes VCF) â†’ ëª¨ë“  GEM1~8 rerun
2. `merger` - CellBender reuse + demux doublet filter
3. `qc_filter` - min_genes=200, min_cells=3, max_mt_pct=20, solo soft filter
4. `solo` - Doublet detection (100 epochs)
5. `integration` - scVI (GPU/RTX4090, n_hvgs=3000, n_latent=30, 200 epochs)

### Souporcell Demux í™•ì¸
- GEM1~8: VCF-based rerun, **Singlets only** (0% doublets in `_notroublet.csv`)
- GEM9~12: No demux path (pre-multiplexed/HT) â†’ Direct barcode whitelist from CellRanger
- HC_GEM04~24: Souporcell with VCF, **doublets detected** (6.6~10.9%)
- **74_3 = GEM8ì˜ sample_id '4-3'** â†’ QC metricsì—ì„œ í™•ì¸ë¨: raw 33,534 â†’ solo_singlet 442 cells

## 3. ë°ì´í„° íŒŒì¼ ìœ„ì¹˜

```
/data/user3/sobj/stroke_hc_v8_2/
â”œâ”€â”€ 1_stroke_hc_integrated.h5ad     (7.6G) - ì›ë³¸ scVI integration output
â”œâ”€â”€ 2_strokev8_meta_add.h5ad        (7.7G) - metadata ì¶”ê°€
â”œâ”€â”€ 2_strokev8_meta_add.qs          (533M) - Seurat ë³€í™˜
â”œâ”€â”€ 3_strokev8_clustered.qs         (9.3G) - Clustering ì™„ë£Œ (res=2, scvi_snn)
â”œâ”€â”€ 4_strokev8_annotated.qs         (9.3G) - anno1/anno2 annotation
â”œâ”€â”€ 5_strokev8_clean.qs             (~8G)  - LQ/RBC/doublet ì œê±° (205,277 cells)
â”œâ”€â”€ 5_1_hc_is.qs                    (~5G)  - HC + IS only (131,552 cells) [Layer 1]
â”œâ”€â”€ 5_2_is_g3.qs                    (~2G)  - IS only with g3 (54,002 cells) [Layer 2 + FGS]
â”œâ”€â”€ results/
â”‚   â”œâ”€â”€ FindMarkers/
â”‚   â”‚   â”œâ”€â”€ 1_fam.csv               - FindAllMarkers ê²°ê³¼
â”‚   â”‚   â””â”€â”€ 1_fam_filtered.csv      - Filtered markers
â”‚   â””â”€â”€ annotation_qc/              - Annotation QC ê²°ê³¼ (2026-02-12)
â”‚       â”œâ”€â”€ centroid_distances_scvi.csv
â”‚       â”œâ”€â”€ cluster_nearest_neighbors.csv
â”‚       â”œâ”€â”€ canonical_marker_dotplot_data.csv
â”‚       â”œâ”€â”€ doublet_coexpression.csv
â”‚       â”œâ”€â”€ suspicious_coexpression.csv
â”‚       â”œâ”€â”€ cluster_cohort_distribution.csv
â”‚       â”œâ”€â”€ cluster_g3_distribution.csv
â”‚       â””â”€â”€ patient_summary.csv
â”œâ”€â”€ fgs/                             - FGS & TML ê²°ê³¼ (ì‹¤í–‰ ì¤‘)
â”‚   â””â”€â”€ whole_IS_{50,100,200}/       - n_features sweep
â”œâ”€â”€ cci/                             - CCI ê²°ê³¼ âœ…
â”‚   â”œâ”€â”€ cellchat/
â”‚   â”‚   â”œâ”€â”€ L1_cohort_anno2/         - HC vs IS (anno2 grouping)
â”‚   â”‚   â”‚   â””â”€â”€ merged/{Stroke,HC}/cellchat_merged.qs
â”‚   â”‚   â””â”€â”€ L2_g3_anno2/            - g3==2 vs g3==1 (anno2 grouping)
â”‚   â”‚       â””â”€â”€ merged/{X1,X2}/cellchat_merged.qs
â”‚   â””â”€â”€ mnn/
â”‚       â”œâ”€â”€ L1_cohort_anno2/multinichenet_results.qs
â”‚       â””â”€â”€ L2_g3_anno2/multinichenet_results.qs
â”œâ”€â”€ trajectory/                      - Trajectory ê²°ê³¼ âœ…
â”‚   â”œâ”€â”€ mono/                        - Monocyte (72K cells)
â”‚   â”‚   â”œâ”€â”€ subset.qs, slingshot_sce.rds, monocle3_cds.rds
â”‚   â”‚   â””â”€â”€ gene_dynamics/*.png
â”‚   â”œâ”€â”€ cd4/                         - CD4+ T (51K cells)
â”‚   â”‚   â””â”€â”€ subset.qs, slingshot_sce.rds, monocle3_cds.rds
â”‚   â””â”€â”€ cd8/                         - CD8+ T (35K cells)
â”‚       â””â”€â”€ subset.qs, slingshot_sce.rds, monocle3_cds.rds
â”œâ”€â”€ MASC/                            - MASC ê²°ê³¼ (6 comparisons done)
â”œâ”€â”€ scripts/                         - ë¶„ì„ ìŠ¤í¬ë¦½íŠ¸
â”‚   â”œâ”€â”€ annotation_qc.R
â”‚   â”œâ”€â”€ create_subsets.R
â”‚   â”œâ”€â”€ run_fgs_sweep.sh
â”‚   â”œâ”€â”€ run_cci_all.sh
â”‚   â”œâ”€â”€ run_trajectory.R
â”‚   â””â”€â”€ run_trajectory_part2.R
â””â”€â”€ logs/                            - ì‹¤í–‰ ë¡œê·¸
```

## 4. Metadata êµ¬ì¡°

### í•µì‹¬ ì»¬ëŸ¼
| Column | Description | Unique | NAs |
|--------|-------------|--------|-----|
| `patient_name` | í™˜ì ID (hos_no) | 100 | 0 |
| `GEM` | GEM batch ID | 17 | 0 |
| `SET` | SET1/2/3, HC_SET1/3 | 5 | 0 |
| `cohort` | Stroke / HC | 2 | 0 |
| `index_injury_hand` | IS/ICH/IVH/SAH/HC | 6 | 0 |
| `project_name` | Stroke / Healthy | 2 | 0 |
| `g3` | **Target variable** (1/2) | 3 | 167,373 âš ï¸ |
| `sex` | M/F | 3 | 7,525 |
| `age` | 25~80+ | 48 | 7,525 |
| `day` | 1/2/3 (sampling day) | 4 | 80,823 |
| `anno1` | Fine annotation | 26 | 0 |
| `anno2` | Major compartments | 8 | 0 |
| `seurat_clusters` | Seurat clusters (res=2) | 36 | 0 |

### âš ï¸ ì¤‘ìš”: g3 NA ë¬¸ì œ
- `g3`ëŠ” IS í™˜ì ì „ìš© â†’ HC/ICH/IVH/SAH ì„¸í¬ëŠ” NA
- FGS/TMLì—ì„œ g3ë¥¼ target_varë¡œ ì‚¬ìš© ì‹œ, `index_injury_hand=="IS"` í•„í„° í•„ìš”
- ë˜ëŠ” HCë¥¼ í¬í•¨í•œ ë¶„ì„ ì„¤ê³„ ì‹œ `cohort` ë˜ëŠ” `project_name` ì‚¬ìš©

### anno1 categories (26ê°œ)
- T/NK: CD4+ T_Naive/Memory, CD8+ T_Cytotoxic, CD8+ Trm, Treg, MAIT, NK_cell, ISG+ T_cell, Proliferating
- Myeloid: CD14+ Monocyte, Inflammatory Monocyte, CD16+ Monocyte, ISG+ Myeloid, Macrophage-like
- DC: cDC1, cDC2, pDC
- B: B_cell, Plasma_cell
- Contam/LQ: Erythrocyte, Platelet/PLA, Mast_cell, T/NK_Low_quality_14, Mono_Low_quality_24, B_Low_quality_31
- Ambiguous: CD4_S100A8_CD14, CD4_S100A8_CSF3R

### anno2 categories (8ê°œ)
Tc, NKc, Mono, DC, Bc, Platelet/PLA, Erythrocyte, Mast_cell

## 5. ë¶„ì„ ì„¤ê³„ (Study Design)

### ë¹„êµ êµ¬ì¡° (Dual-layer comparison)
```
Layer 1: HC vs IS (cohort-level)
  - Cell cluster frequency ì°¨ì´
  - DEG ì°¨ì´
  - CCI ì°¨ì´
  â†’ "Strokeê°€ ë©´ì—­ landscapeë¥¼ ì–´ë–»ê²Œ ë°”ê¾¸ëŠ”ê°€?"

Layer 2: IS ë‚´ g3==1 (good) vs g3==2 (bad)
  - ê°™ì€ ë¶„ì„ì„ IS ë‚´ì—ì„œ ë°˜ë³µ
  - FGS/TMLë¡œ ì˜ˆí›„ ì¸ì(gene signature) íƒìƒ‰
  â†’ "ê°™ì€ IS í™˜ì ì¤‘ ì™œ ì–´ë–¤ í™˜ìëŠ” ì˜ˆí›„ê°€ ë‚˜ìœê°€?"

Cross-layer insight:
  - Layer 1ê³¼ Layer 2ì—ì„œ ìœ ì‚¬í•œ íŒ¨í„´ì´ ë°œê²¬ë˜ë©´ í¥ë¯¸ë¡œìš´ ê²°ê³¼
  - ì˜ˆ: g3==2 (bad outcome)ì˜ ë©´ì—­ í”„ë¡œí•„ì´ HCì—ì„œ ë” ë²—ì–´ë‚˜ ìˆëŠ”ê°€?
  - "severe stroke" phenotypeì˜ ë©´ì—­í•™ì  íŠ¹ì„± ê·œëª…
```

### g3 ì •ì˜
- **g3==1**: IS í™˜ì ì¤‘ IAT ì‹œí–‰ í›„ ì˜ˆí›„ ì–‘í˜¸ (good outcome)
- **g3==2**: IS í™˜ì ì¤‘ IAT ì‹œí–‰ í›„ ì˜ˆí›„ ë¶ˆëŸ‰ (bad outcome)
- **NA**: HC, ICH, IVH, SAH í™˜ì â†’ g3 í•´ë‹¹ ì—†ìŒ

### Annotation ì „ëµ (í™•ì •)
- **PLT(Platelet) ìœ ì§€**: PMA(Platelet-Monocyte Aggregate) ê´€ì°° ê°€ëŠ¥ì„± â†’ PPBP+CD14 co-expression í™•ì¸
- **RBC(Erythrocyte) ì œê±°**: ë¶„ì„ì— ë¶ˆí•„ìš”
- **Low quality clusters ì œê±°**: cluster 14(T/NK_LQ), 24(Mono_LQ), 31(B_LQ)
- **Ambiguous clusters ì¬í‰ê°€ í•„ìš”**:
  - CD4_S100A8_CD14 (cluster 19): T+Myeloid marker co-expression â†’ doublet vs. ì‹¤ì œ ì„¸í¬
  - CD4_S100A8_CSF3R (cluster 25): ë™ì¼ ì´ìŠˆ
- **Annotation QC ì „ëµ**:
  1. Canonical marker expression í™•ì¸ (ì ˆëŒ€ì  ë°œí˜„ ìˆ˜ì¤€, ìƒëŒ€ì  DEGê°€ ì•„ë‹Œ)
  2. Mutually exclusive marker co-expression í‰ê°€ (CD3 vs CD14 ë“±) â†’ doublet íŒë³„
  3. Cluster centroid ê°„ ê±°ë¦¬ ê³„ì‚° â†’ ì´ìƒ í´ëŸ¬ìŠ¤í„° íƒì§€
  4. PERMANOVA / LISI ì§€í‘œ í‰ê°€ â†’ batch/integration quality í™•ì¸

## 6. ì´ë¯¸ ì™„ë£Œëœ ë¶„ì„

### âœ… Pipeline (mypy_re)
- CellBender, Souporcell, Solo, scVI integration

### âœ… Clustering & Annotation
- FindAllMarkers (res=2) â†’ `1_fam.csv`
- anno1 (26 types), anno2 (8 compartments) â†’ `4_strokev8_annotated.qs`

### âœ… MASC (Frequency Analysis)
- 6 MASC runs completed:
  - cluster1(seurat_clusters) Ã— comparison1(project_name) / comparison2(g3)
  - cluster2(anno1) Ã— comparison1 / comparison2
  - cluster3(anno2) Ã— comparison1 / comparison2
- Forest plots, p-value bar plots ìƒì„±ë¨

### ğŸ”² ë¯¸ì™„ë£Œ (ì‹¤í–‰ í•„ìš”)
1. **Annotation QC & Refinement** - doublet/LQ ì œê±°, ambiguous cluster í•´ê²°
2. **MILO** - ì½”ë“œ ë¹„ì–´ìˆìŒ (plotting sectionë§Œ)
3. **FGS & TML** - ìŠ¤í¬ë¦½íŠ¸ ì¡´ì¬, ìƒˆ ë°ì´í„°ë¡œ ì‹¤í–‰ í•„ìš”
4. **CCI (CellChat + MultiNicheNet)** - ìŠ¤í¬ë¦½íŠ¸ ì¡´ì¬, ìƒˆ ë°ì´í„°ë¡œ ì‹¤í–‰ í•„ìš”
5. **Trajectory Analysis** - compartmentë³„ ì„¤ê³„ í•„ìš”
6. **Subclustering** - ê°œë³„ compartmentë³„ scVI re-integration í•„ìš”

## 7. ì‹¤í–‰ ê³„íš

### Phase 1: Annotation QC & Data Preparation
1. **Annotation refinement**:
   - [ ] Cluster centroid ê±°ë¦¬ ê³„ì‚° â†’ ì´ìƒ í´ëŸ¬ìŠ¤í„° íƒì§€
   - [ ] Canonical marker ì ˆëŒ€ ë°œí˜„ëŸ‰ í‰ê°€ (pct.exp + avg_exp)
   - [ ] Doublet co-expression í‰ê°€ (CD3 vs CD14, CD3 vs CD79A, etc.)
   - [ ] LQ cluster(14,24,31) + Erythrocyte(27,34) ì œê±°
   - [ ] Ambiguous cluster(19,25) íŒì •: doubletì´ë©´ ì œê±°, ì•„ë‹ˆë©´ re-annotate
   - [ ] PLT ìœ ì§€ (PMA ê°€ëŠ¥ì„±)
2. **Subset ìƒì„±**:
   - [ ] `sobj_clean`: LQ/Erythrocyte ì œê±° í›„ ì „ì²´ (HC + IS + ê¸°íƒ€)
   - [ ] `sobj_hc_is`: HC + IS only (Layer 1 ë¹„êµìš©)
   - [ ] `sobj_is`: IS only with valid g3 (Layer 2 ë¹„êµìš©)
3. **ê¸°ì´ˆ í†µê³„**:
   - [ ] g3 group ë¶„í¬ (í™˜ì ìˆ˜, ì„¸í¬ ìˆ˜)
   - [ ] HC vs IS cell composition ë¹„êµ
   - [ ] PERMANOVA / LISI batch quality í™•ì¸

### Phase 2: FGS & TML â†’ ğŸ”„ ì‹¤í–‰ ì¤‘ (n=50: 5/10 methods done)
**Script**: `/home/user3/data_user3/git_repo/mylit/Git_Repo/_wt/fgs/scripts/fgs/run_fgs_pipeline.R`
**Sweep script**: `scripts/run_fgs_sweep.sh` (taskset -c 0-15, 16 cores)

#### Run 1: ì „ì²´ IS (g3 target) - ì‹¤í–‰ ì¤‘
- `--input`: `5_2_is_g3.qs` (54,002 cells)
- `--output`: `fgs/whole_IS_{50,100,200}/`
- `--target_var g3`, `--control_vars "sex,age,GEM"`
- `--n_features`: 50 (ì‹¤í–‰ ì¤‘), 100, 200 (ëŒ€ê¸°)

**ì§„í–‰ ìƒí™©** (n_features=50):
| Method | Time | Status |
|---|---|---|
| random_forest_ranger | 128 min | âœ… |
| lasso | 91 min | âœ… |
| ridge | 385 min | âœ… |
| elastic_net | 93 min | âœ… |
| pca_loadings | ? | ğŸ”„ ì‹¤í–‰ ì¤‘ |
| nmf | - | ëŒ€ê¸° |
| gam | - | ëŒ€ê¸° |
| limma | - | ëŒ€ê¸° |
| wilcoxon | - | ëŒ€ê¸° |
| xgboost | - | ëŒ€ê¸° |

**ì£¼ì˜**: CPU limitation (taskset), NMF convergence, ridgeê°€ ë§¤ìš° ëŠë¦¼(6.5h)

### Phase 3: CCI (Dual-layer) â†’ âœ… ì™„ë£Œ + í•´ì„ (2026-02-13)

#### Layer 1: HC vs IS (CellChat)
- HC: mean 114.75 interactions, strength 7.35
- Stroke: mean 72.39 interactions, strength 5.00
- **Strokeì—ì„œ ì „ë°˜ì  CCI 37% ê°ì†Œ** â†’ Stroke-Induced Immunosuppression (SIIS)
- DC hub ì¤‘ì‹¬ ê°ì†Œ (Monoâ†’DC, DCâ†’DC, NKcâ†’DC ëª¨ë‘ ê°ì†Œ)
- HCì˜ DCëŠ” highest sender+receiver â†’ Strokeì—ì„œ DC ê¸°ëŠ¥ ì €í•˜
- MNN ë¦¬ê°„ë“œ í™œì„±: IL-10, IL-4 (í•­ì—¼ì¦), CCL11, TGFB2 â†’ ë©´ì—­ì–µì œ milieu
- NLGN1/3 (ì‹ ê²½ ë¦¬ê°„ë“œ) â†’ NKc íƒ€ê²Ÿ: ë‡Œì¡¸ì¤‘ í›„ ì‹ ê²½ ì†ìƒ ì‹ í˜¸?

#### Layer 2: IS g3_Bad vs g3_Good (CellChat)
- g3_Bad: mean 76.24 interactions, strength 5.19
- g3_Good: mean 69.18 interactions, strength 4.71
- **Badì—ì„œ ~10% ë” ë§ì€ interaction**
- **Monoâ†’DC, Monoâ†’Bc ì¦ê°€** (myeloidâ†’APC axis ê°•í™”)
- Bc autocrine ì¦ê°€, NKc ê´€ë ¨ signaling ê°ì†Œ
- MNN ë¦¬ê°„ë“œ í™œì„±: IFN-I/II/III (IFNB1, IFNG, IL27), MMP1 â†’ ì¸í„°í˜ë¡  ë°˜ì‘ signature
- í•´ì„: Bad outcome = ë¹„ì •ìƒì  myeloidâ†’APC í™œì„±í™” + NK ê¸°ëŠ¥ ì €í•˜

#### MNN ì£¼ì˜ì‚¬í•­
- **anno2 ë ˆë²¨ì—ì„œ group_prioritization_tbl = 0 rows** (both layers)
- DE ìœ ì˜ ìœ ì „ì: L2ì—ì„œ 1ê°œ(Bc), L1ì—ì„œ 0ê°œ â†’ anno2ê°€ ë„ˆë¬´ coarse
- **ligand_activities_target_de_tblì€ ì •ìƒ ì‘ë™** (L2: 105K rows, L1: 229K rows)
- **ê¶Œì¥**: anno1 ë ˆë²¨ (26 types)ìœ¼ë¡œ MNN ì¬ì‹¤í–‰

#### ì¶œë ¥ íŒŒì¼
```
cci/plots/
â”œâ”€â”€ cellchat_L2_g3/         # 8 comparison plots + pathways/
â”œâ”€â”€ cellchat_L1_cohort/     # 8 comparison plots + pathways/
â”œâ”€â”€ mnn_L2_g3_anno2/        # DE volcanos, ligand activities (LR empty)
â””â”€â”€ mnn_L1_cohort_anno2/    # DE volcanos, ligand activities (LR empty)
```

### Phase 4: Trajectory Analysis

#### v1 (trajectory/) â†’ âœ… ì™„ë£Œ (2026-02-12) â€” **superseded by v2**
- subset ë‚´ PCA/UMAP ì¬ê³„ì‚° â†’ HC/Stroke batch effect ë¯¸ë³´ì • ë¬¸ì œ
- gene dynamics: raw counts, ê¸°ìˆ ì  ë³´ì • ì—†ìŒ

#### v2 (trajectory_v2/) â†’ âœ… ì™„ë£Œ (2026-02-13) â€” scVI UMAP ì‚¬ìš©
- **í•µì‹¬ ìˆ˜ì •**: ì›ë³¸ `umap.scvi` embedding ì‚¬ìš© (batch-corrected)
- ëª¨ë“  scatter plot â†’ PNG (dpi=150)
- HC vs Stroke ë¹„êµ (Layer 1) ì¶”ê°€

| Compartment | Cells | Pseudotime | g3 Wilcoxon | Cohort Wilcoxon |
|---|---|---|---|---|
| **Monocyte** | 72,163 | 0 - 2.69 | **< 2e-16** | **< 2e-16** |
| **CD4+ T** | 50,996 | 0 - 2.06 | **0.028** | **< 2e-16** |
| **CD8+ T** | 35,295 | TBD | TBD | TBD |

**í•µì‹¬ ë°œê²¬**:
- Mono: HCëŠ” ì¤‘ê°„~í›„ë°˜ pseudotimeì— ë¶„í¬ â†’ ì •ìƒ ë¶„í™”. StrokeëŠ” ì´ˆê¸°ì— ì§‘ì¤‘ â†’ ë¶„í™” ì •ì²´
- g3_Bad: pseudotime ~0ì— ì§‘ì¤‘ â†’ ìµœì´ˆ ë¶„í™” ë‹¨ê³„ì—ì„œ ë©ˆì¶¤
- CD4: ìœ ì‚¬í•œ íŒ¨í„´ì´ë‚˜ effect size ì‘ìŒ

#### Gene Dynamics v1/v2: `expr ~ s(pseudotime, by=cond)` â€” batch ë³´ì • ì—†ìŒ
- âš ï¸ raw UMI counts ì‚¬ìš©, GEM batch/library size/percent.mt ë¯¸ë³´ì •
- outlier ë•Œë¬¸ì— yì¶• ìŠ¤ì¼€ì¼ ë¬¸ì œ (S100A8 ë“±)

#### Gene Dynamics v3: Batch-corrected GAMM â†’ ìŠ¤í¬ë¦½íŠ¸ ì¤€ë¹„ ì™„ë£Œ
- **í•¨ìˆ˜**: `analyze_gene_dynamics_v2()` in `myR/R/analysis/pseudotime.R`
- **ëª¨ë¸**: `expr ~ s(pt) + cond + s(pt, by=cond) + offset(log(nCount_RNA)) + percent.mt + s(GEM, bs="re")`
- family: NB(log), REML
- yì¶•: 99th percentile clipping
- ì˜ˆì¸¡ ê³¡ì„ : reference covariate values, batch RE marginalised
- **ìŠ¤í¬ë¦½íŠ¸**: `scripts/run_gene_dynamics_v3.R`
- **ì¶œë ¥**: `trajectory_v3/{comp}/gene_dynamics_{g3,cohort}/`
- **ë°©ë²•ë¡  ë¬¸ì„œ**: `docs/gene_dynamics_approaches.md`

#### Two-stage pseudobulk approach (í–¥í›„ ê³„íš)
- Patient Ã— pseudotime binìœ¼ë¡œ aggregation â†’ edgeR/limma-voom
- Patient RE í¬í•¨ ê°€ëŠ¥ (pseudoreplication í•´ê²°)
- ìƒì„¸: `docs/gene_dynamics_approaches.md`

#### ì°¸ê³ 
- Slingshot: umap_scvi (2D) + approx_points=150
- Monocle3: ì›ë³¸ umap_scvi ì£¼ì…, use_partition=FALSE, root_cells 500ê°œ sampling
- `dplyr::first()` masking ì£¼ì˜ (Bioconductorë³´ë‹¤ dplyr ë§ˆì§€ë§‰ ë¡œë“œ)

## 8. ë‹µë³´ìƒíƒœ ì´ìŠˆ

### Issue 1: Annotation ë¶ˆëª…í™•ì„± â†’ âœ… í•´ê²° (2026-02-12)

**Annotation QC ìˆ˜í–‰** (centroid distance + canonical marker + co-expression ë¶„ì„):

| Cluster | anno1 | Cells | ê²°ì • | ê·¼ê±° |
|---------|-------|-------|------|------|
| 13 | Macrophage-like | 7,435 | **ì œê±° (doublet)** | CD3D+CD14=38%, CD3D+LYZ=48%, NKG7+CD14=46% |
| 22 | Plasma_cell | 3,020 | **ì œê±° (doublet)** | MS4A1+CD14=29%, CD3D+MS4A1=24%, NKG7+CD14=23% |
| 14 | T/NK_LQ | 6,498 | **ì œê±° (LQ)** | |
| 24 | Mono_LQ | 2,810 | **ì œê±° (LQ)** | |
| 31 | B_LQ | 519 | **ì œê±° (LQ)** | |
| 27,34 | Erythrocyte | 1,296 | **ì œê±° (RBC)** | |
| 19 | CD4_S100A8_CD14 | 4,735 | **ìœ ì§€ â†’ CD4+T_S100A8_stress** | CD3D+CD14=0.02%, CD3D=69%. S100A8 stress response |
| 25 | CD4_S100A8_CSF3R | 2,747 | **ìœ ì§€ â†’ T/NK_activated** | CD3D+CD14=0%, NKG7=34%. CSF3R expressing T/NK |
| 28 | Platelet/PLA | 824 | **ìœ ì§€** | PMA ë¶„ì„ìš© (PPBP+CD14 co-expression ê´€ì°° ê°€ëŠ¥) |

**ì œê±° ì´ê³„**: ~21,578 cells â†’ ê¹¨ë—í•œ ë°ì´í„° ~205,277 cells

### Issue 2: Souporcell/Demux ê²€ì¦ â†’ âœ… í™•ì¸ë¨
- GEM8ì˜ 74_3 (=4-3): 880 demux assigned â†’ 877 QC â†’ **442 solo singlets** (ë§¤ìš° ì ìŒ)
- GEM9~12: No souporcell demux â†’ CellRanger barcode whitelist ì§ì ‘ ì‚¬ìš©
- HC GEMs: Doublet rate 6.6~10.9% â†’ ì •ìƒ ë²”ìœ„

### Issue 3: g3 NA ëŒ€ì‘ â†’ Dual-layer ì„¤ê³„ë¡œ í•´ê²°
- Layer 1: HC vs IS (cohort ê¸°ì¤€, g3 ë¶ˆí•„ìš”)
- Layer 2: IS ë‚´ g3==1 vs g3==2 (IS only subset)
- **g3 ë¶„í¬**: g3==1 (good) 11ëª…, g3==2 (bad) 21ëª…, ì´ 32 IS patients (59,482 cells)

## 9. ì°¸ê³  íŒŒì¼

- **Master Rmd**: `/home/user3/GJC_KDW_250721/rmd/AfterPipe_260205.Rmd`
- **myR Package**: `/data/user3/git_repo/mylit/myR/R/`
- **FGS/TML Guide**: `docs/fgs/FGS_TML_INTEGRATED_GUIDE.md`
- **CCI Guide**: `docs/cci/CCI_INTEGRATED_GUIDE.md`
- **Pseudotime Guide**: `docs/pseudotime-dev/PSEUDOTIME_INTEGRATED_GUIDE.md`
- **Clinical Metadata**: `/home/user3/Clinical information/meta_data_prep_260121.csv`
- **QC Metrics**: `/home/user3/data_user3/git_repo/mypy_re/report/qc_sample_metrics.csv`
